Health

New South Wales Government (NSW) Partner, Myeloid Therapeutics, Initiates Patient Dosing with MT-302 in Phase 1 Study at Clinical Site in Australia

NSW and Myeloid entered into a partnership in February 2023 to launch state-of-the-art GMP manufacturing RNA facility CAMBRIDGE, Mass., Sept. 12, 2023 /PRNewswire/ -- Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage oncology company, has dosed the first patient with MT-302 in a Phase 1 s...

2023-09-12 20:00 1092

Pierre Fabre Laboratories Acquires Vertical Bio and its Innovative Targeted Therapy Candidate for Patients Suffering From Non-Small Cell Lung Cancer With MET Alteration

CASTRES, France and BASEL, Switzerland, Sept. 12, 2023 /PRNewswire/ --  Pierre Fabre Laboratories , the French pharmaceutical and dermo-cosmetic company, announced the acquisition of Vertical Bio AG, a developer of novel cancer therapies. This first acquisition of...

2023-09-12 20:00 1541

Metabolon Launches New Biological Stress Discovery Panel to Aid Detection of Inflammation and Biological Stress Biomarkers

Metabolon's new Biological Stress Discovery Panel supports inflammation, immune function, and stress research with advanced analytics  MORRISVILLE, N.C., Sept. 12, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of research, di...

2023-09-12 19:57 1159

The Korean Society of Ginseng confirms the effects of consuming red ginseng in the prevention and improvement of dementia

- Through the study "Elucidation of Mechanisms for Dementia Prevention and Improvement by Red Ginseng" SEOUL, South Korea, Sept. 12, 2023 /PRNewswire/ -- Through continuous research, the secrets of ginseng, a representative medicinal herb of Korea, are being revealed, showcasing its efficacy. Re...

2023-09-12 17:00 2064

Study Validates Lunit AI as a Game-Changer, Poised to Replace One Human Reader in Breast Cancer Screening

* Lunit's collaborative study supports AI as a viable alternative to one human reader inEurope's double reading system - published in The Lancet Digital Health SEOUL, South Korea, Sept. 12, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagno...

2023-09-12 13:03 2161

Gates Foundation Goalkeepers Report Says Seven Innovations Could Save 2 Million Mothers and Babies by 2030

Melinda French Gates and Bill Gates call for urgent action to advance progress on the UN's Sustainable Development Goals and shine a spotlight on reducing maternal and child mortality SEATTLE, Sept. 12, 2023 /PRNewswire/ -- The Bill & Melinda Gates Foundation today released its seventh annual Go...

2023-09-12 12:01 1800

When is it too late for a 'fairy tale ending' for women electing to freeze their oocytes?

ADELAIDE, Australia, Sept. 12, 2023 /PRNewswire/ -- Around the world, soaring numbers of women are electing to freeze their eggs to preserve their fertility, and many do so in anticipation of a "fairy tale ending" with the birth of a healthy baby. However, a reality check is needed to manage t...

2023-09-12 09:28 1620

MGI Launches the DCS Lab Initiative to Expand Global Omics Access and Capabilities

SHENZHEN, China, Sept. 11, 2023 /PRNewswire/ -- MGI, a company committed to building core tools and technology to lead life science, today announced the DCS Lab Initiative to help facilitate large-scale leading multi-omics laboratories and spur critical scientific research. Under the initiative, ...

2023-09-11 19:43 1176

IPMG Drives Health Transformation and Strengthens Indonesia's Economy Through Efforts to Accelerate Access to Innovative Medicines and Vaccines, also Partnerships

JAKARTA,  Indonesia, Sept. 11, 2023 /PRNewswire/ -- The research and development-based multinational pharmaceutical industry association, the International Pharmaceutical Manufacturers Group (IPMG) is always committed to supporting and encouraging advocacy and transformation of Government policie...

2023-09-11 18:52 2090

KT&G and the Indonesian Ministry of Investment jointly conduct investment support ceremony for KT&G's new manufacturing plant construction in Indonesia

* The new manufacturing plant is expected to commence production in 2026…expected to serve as an export hub SEOUL, South Korea, Sept. 11, 2023 /PRNewswire/ -- KT&G Corporation ("KT&G") (KRX:033780) conducted an investment support ceremony with the Indonesian Ministry of Investment and obtained ...

2023-09-11 17:29 4681

Norgine Strengthens Senior Leadership with the Appointment of Saulo Martiniano as Chief Operating Officer

AMSTERDAM, Sept. 11, 2023 /PRNewswire/ -- Norgine, a leading European specialist pharmaceutical company dedicated to improving the lives of patients, is pleased to announce the appointment ofSaulo Martiniano as its new Chief Operating Officer (COO). Saulo joins Norgine with a wealth of experience...

2023-09-11 15:00 1349

Can we really make a difference in reducing the heartbreak of millions of miscarriages each year?

ADELAIDE, Australia, Sept. 11, 2023 /PRNewswire/ -- Globally, one in six pregnancies end in miscarriage, which is generally defined as the loss of an intrauterine pregnancy before viability. This equates to an estimated 23 million miscarriages every year, or over 40 miscarriages per minute. Th...

2023-09-11 14:58 1619

Biosyngen received FDA approval for Phase I/II Clinical Trials for BRL03, targeting Lung Cancer, Gastric Cancer and other advanced Solid Tumors

SINGAPORE, Sept. 11, 2023 /PRNewswire/ -- On September 9th, 2023, Biosyngen Pte Ltd (hereafter as "Biosyngen") announced that the U.S. FDA has cleared the Investigational New Drug (IND) application for Phase I/II clinical trial ofBRL03 for the treatment of lung cancer, gastric cancer and other ad...

2023-09-11 14:53 1473

PeproMene Bio, Inc. Announced Completion of the First Dose Cohort and Opening of the Second Dose Cohort in Its B-cell Non-Hodgkin Lymphoma (B-NHL) Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells)

IRVINE, Calif., Sept. 11, 2023 /PRNewswire/ -- PeproMene Bio, Inc., a clinical-stage biotech company developing novel therapies to treat cancers and immune disorders, today announced that the first dose cohort of its phase 1 relapsed or refractory B-cell Non-Hodgkin Lymphoma (r/r B-NHL) clinical ...

2023-09-11 12:05 2241

The social, economic and political reality for many girls cast aside in cultural gender selection

ADELAIDE, Australia, Sept. 11, 2023 /PRNewswire/ -- Deep rooted historical preference for sons over daughters continues to be customary in some East and South Asian countries devaluing women and posing long term threats to society. This disturbing situation, often leading to female feticide – o...

2023-09-11 10:35 1714

Kidney Dialysis Foundation Unveils First In-Person 'Got To Walk 2023: Illuminating Life' Event To Raise Funds For Needy Kidney Patients

Illuminating the lives of needy kidney patients by walking together for a good cause.     SINGAPORE, Sept. 11, 2023 /PRNewswire/ -- The Kidney Dialysis Foundation (KDF) is thrilled to unveil the inaugural in-person edition of the 'Got To Walk 2023: Illuminating Life' walkathon, a flagship fundra...

2023-09-11 09:00 1407

Target Global Acquisition I Corp. Announces Extension of Deadline to Complete Initial Business Combination

BERLIN, Sept. 9, 2023 /PRNewswire/ -- Target Global Acquisition I Corp. (Nasdaq: TGAA) (the "Company") announced today that its board of directors (the "Board"), upon request of Target Global Sponsor Ltd (the "Sponsor"), has decided to extend the date by which the Company must consummate an initi...

2023-09-09 04:03 7857

Introducing BIOSTAR® cutting-edge Conventional TBNA (cTBNA) and Endobronchial ultrasound (EBUS) TBNA (EBUS-TBNA) needle: Revolutionizing Minimally Invasive Diagnostic techniques

SAN JOSE, Calif., Sept. 9, 2023 /PRNewswire/ -- In a remarkable stride towards advancing medical technology, we are thrilled to announce the launch of our groundbreaking BioStar® Transbronchial Aspiration Needle (TBNA) designed to transform the landscape of minimally invasive diagnostics. This in...

2023-09-09 01:30 2713

Sirtex Medical Announces Collaboration Agreement with Magle Group for EmboCept® S DSM 50 μm

Sirtex partners with Magle Group to advance the international treatment of liver and lung cancer WOBURN, Mass., Sept. 8, 2023 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of interventional treatment solutions, announced today the establishment of a collaboration and exclusiv...

2023-09-08 22:45 2255

Omega Healthcare Celebrates 20 Years of Excellence and Innovation in Healthcare Outsourcing Solutions

Two decades of empowering healthcare organizations to deliver exceptional care and enhance their financial performance BOCA RATON, Fla., Sept. 8, 2023 /PRNewswire/ -- Omega Healthcare, a leading healthcare company, is excited to announce the celebration of its 20th anniversary. This significant ...

2023-09-08 21:00 1664
1 ... 124125126127128129130 ... 581